OPY vs SRPT · P/E 13, rev $1.43B vs rev $1.90B
Oppenheimer Holdings Inc (OPY) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
OPY currently screens at market cap $1.15B and trailing P/E 12.8. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the OPY and SRPT stock pages for the full models.
Not investment advice.